Help From the Hill Could Add to Pharma ETFs’ Gains

Congress is working on reform legislation in the pharmaceutical industry to stomp out copycat drug makers, lifting large pharmaceutical stocks and related exchange traded funds. The SPDR S&P Pharmaceuticals ETF (NYSEArca: XPH) was the best performing non-leveraged ETF over the past week,...